Search Login Register

Breast Neoplasms (Breast Cancer) Summary

Description: Tumors or cancer of the human BREAST.

Also Known As: Breast Cancer; Cancer, Breast; Breast Tumors; Neoplasms, Breast; Cancer of Breast Show All >>

Networked: 106981 relevant articles (6408 outcomes, 24352 trials/studies) for this Disease

Key Drugs and Agents for Breast Neoplasms

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Tamoxifen : 704 outcomes 1853 studies in 6847 results : FDA 12 Generic
  2. trastuzumab (Herceptin) : 523 outcomes 835 studies in 3210 results : FDA 2
  3. Estrogens (Estrogen) : 379 outcomes 1754 studies in 12895 results : FDA 1
  4. Paclitaxel (Taxol) : 336 outcomes 786 studies in 2235 results : FDA 13 Generic
  5. Hormones : 331 outcomes 1198 studies in 7766 results : IBA
  6. docetaxel (Taxotere) : 313 outcomes 780 studies in 1695 results : FDA 3
  7. Doxorubicin (Adriamycin) : 262 outcomes 845 studies in 2924 results : FDA 12 Generic
  8. Cyclophosphamide (Cytoxan) : 212 outcomes 796 studies in 2245 results : FDA 10 Generic
  9. capecitabine (Xeloda) : 175 outcomes 352 studies in 787 results : FDA 1
  10. Aromatase Inhibitors : 162 outcomes 236 studies in 1405 results : IBA
Show All >>

Diseases Related to Breast Neoplasms

  1. Neoplasms (Cancer)
  2. Neoplasm Metastasis (Metastasis)
  3. Breast Neoplasms (Breast Cancer)
  4. Carcinoma (Carcinomatosis)
  5. Pain (Aches)
Show All >>

Key Therapies for Breast Neoplasms

Efficacy Chart >>
  1. Drug Therapy (Chemotherapy) : 1017 outcomes 2884 studies in 11921 results
  2. Adjuvant Chemotherapy : 181 outcomes 621 studies in 2582 results
  3. Radiotherapy : 172 outcomes 701 studies in 4122 results
  4. Mastectomy (Mammectomy) : 145 outcomes 473 studies in 3295 results
  5. Heterologous Transplantation (Xenotransplantation) : 139 outcomes 292 studies in 2066 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.